The PD-1/PD-L1 pathway plays a pivotal role in immune escape in cancers and in hepatocellular carcinoma [8] and studies have shown a survival advantage in patients with HCC tumors expressing higher levels of PD-L1 [9]. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.